𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report

✍ Scribed by Linch, DC; Vaughan Hudson, B; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, DW; Stevenson, PA; Wood, JK; MacLennan, KA

Book ID
109837271
Publisher
Nature Publishing Group
Year
1996
Tongue
English
Weight
974 KB
Volume
74
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Equitoxicity of bolus and infusional eto
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)
✍ Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; M πŸ“‚ Article πŸ“… 2008 πŸ› Springer 🌐 English βš– 259 KB
Four versus six courses of a dose-escala
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma
✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 252 KB